These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. [Effects of PNPLA3, TM6SF2 gene polymorphisms and its interactions with smoking and alcohol drinking on hepatitis B virus-associated hepatocellular carcinoma]. Wang LQ; Guo WH; Guo ZW; Qin P; Zhang R; Zhu XM; Liu DW Zhonghua Liu Xing Bing Xue Za Zhi; 2018 Dec; 39(12):1611-1616. PubMed ID: 30572387 [No Abstract] [Full Text] [Related]
8. Interaction between estrogen receptor-α and PNPLA3 p.I148M variant drives fatty liver disease susceptibility in women. Cherubini A; Ostadreza M; Jamialahmadi O; Pelusi S; Rrapaj E; Casirati E; Passignani G; Norouziesfahani M; Sinopoli E; Baselli G; Meda C; Dongiovanni P; Dondossola D; Youngson N; Tourna A; Chokshi S; Bugianesi E; ; Della Torre S; Prati D; Romeo S; Valenti L Nat Med; 2023 Oct; 29(10):2643-2655. PubMed ID: 37749332 [TBL] [Abstract][Full Text] [Related]
9. Identification of a Metabolic, Transcriptomic, and Molecular Signature of Patatin-Like Phospholipase Domain Containing 3-Mediated Acceleration of Steatohepatitis. Banini BA; Kumar DP; Cazanave S; Seneshaw M; Mirshahi F; Santhekadur PK; Wang L; Guan HP; Oseini AM; Alonso C; Bedossa P; Koduru SV; Min HK; Sanyal AJ Hepatology; 2021 Apr; 73(4):1290-1306. PubMed ID: 33131062 [TBL] [Abstract][Full Text] [Related]
10. Hepatic patatin-like phospholipase domain-containing 3 levels are increased in I148M risk allele carriers and correlate with NAFLD in humans. Ericson E; Bergenholm L; Andréasson AC; Dix CI; Knöchel J; Hansson SF; Lee R; Schumi J; Antonsson M; Fjellström O; Nasr P; Liljeblad M; Carlsson B; Kechagias S; Lindén D; Ekstedt M Hepatol Commun; 2022 Oct; 6(10):2689-2701. PubMed ID: 35833455 [TBL] [Abstract][Full Text] [Related]
11. Impact of PNPLA3 I148M on alpha-1 antitrypsin deficiency-dependent liver disease progression. Volkert I; Fromme M; Schneider C; Candels L; Lindhauer C; Su H; Thorhauge K; Pons M; Mohamed MR; Schneider KM; Strnad P; Trautwein C Hepatology; 2024 Apr; 79(4):898-911. PubMed ID: 37625151 [TBL] [Abstract][Full Text] [Related]
12. Association Between PNPLA3 rs738409 C>G Variant and Liver-Related Outcomes in Patients With Nonalcoholic Fatty Liver Disease. Grimaudo S; Pipitone RM; Pennisi G; Celsa C; Cammà C; Di Marco V; Barcellona MR; Boemi R; Enea M; Giannetti A; Spatola F; Marchesini G; Craxì A; Petta S Clin Gastroenterol Hepatol; 2020 Apr; 18(4):935-944.e3. PubMed ID: 31419571 [TBL] [Abstract][Full Text] [Related]
13. Genetic variants in PNPLA3 and TM6SF2 predispose to the development of hepatocellular carcinoma in individuals with alcohol-related cirrhosis. Stickel F; Buch S; Nischalke HD; Weiss KH; Gotthardt D; Fischer J; Rosendahl J; Marot A; Elamly M; Casper M; Lammert F; McQuillin A; Zopf S; Spengler U; Marhenke S; Kirstein MM; Vogel A; Eyer F; von Felden J; Wege H; Buch T; Schafmayer C; Braun F; Deltenre P; Berg T; Morgan MY; Hampe J Am J Gastroenterol; 2018 Oct; 113(10):1475-1483. PubMed ID: 29535416 [TBL] [Abstract][Full Text] [Related]
14. PNPLA3 I148M variant and hepatocellular carcinoma: a common genetic variant for a rare disease. Valenti L; Dongiovanni P; Ginanni Corradini S; Burza MA; Romeo S Dig Liver Dis; 2013 Aug; 45(8):619-24. PubMed ID: 23333103 [TBL] [Abstract][Full Text] [Related]
15. PNPLA3 in end-stage liver disease: alcohol consumption, hepatocellular carcinoma development, and transplantation-free survival. Friedrich K; Wannhoff A; Kattner S; Brune M; Hov JR; Weiss KH; Antoni C; Dollinger M; Neumann-Haefelin C; Seufferlein T; Schemmer P; Schirmacher P; Stremmel W; Gotthardt DN J Gastroenterol Hepatol; 2014; 29(7):1477-84. PubMed ID: 25273282 [TBL] [Abstract][Full Text] [Related]